An analysis of China's national essential medicines policy

被引：0
|
作者：
Xiaodong Guan
Huigang Liang
Yajiong Xue
Luwen Shi
机构：
[1] Peking University,Department of Pharmacy Administration and Clinical Pharmacy
[2] Center for Health Management Systems,undefined
[3] College of Business,undefined
[4] East Carolina University,undefined
[5] International Research Center of Medicinal Administration,undefined
[6] Peking University,undefined
来源：
Journal of Public Health Policy | 2011年 / 32卷
关键词：
essential medicines; China; pharmaceutical policy; health-care reform;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Although China embraced the concept of essential medicines in 1979 and issued its first National Essential Medicines List in 1982, until recently China has lacked a comprehensive national essential drug policy. In its most recent health-care reform (2009–2012), the Chinese government explicitly proposed the establishment of a national essential medicines system, and made it one of five top priorities in the coming years. We review the evolution of China's essential medicines policies, explain the importance of fully implementing the essential medicines policy, and analyze recent policy developments surrounding essential medicines.
引用
收藏
页码：305 / 319
页数：14
相关论文
共 50 条
  • [41] NOACs Added to WHO's Essential Medicines List: Recommendations for Future Policy Actions
    Di Cesare, Mariachiara
    Jarvis, Jordan D.
    Scarlatescu, Oana
    Leng, Xinyi
    Zaidel, Ezequiel J.
    Burrone, Esteban
    Eisele, Jean-Luc
    Prabhakaran, Dorairaj
    Sliwa, Karen
    GLOBAL HEART, 2020, 15 (01)
  • [42] National medicines policy development, Saudi Arabia
    Almoteiry, Khalid
    Alharf, Adel
    Al Hammad, Bandar
    Aljuffali, Ibrahim
    Al-Azemi, Nahar
    Al-Ghaith, Taghred
    Alhomidi, Shahad
    Alshehri, Ahlam
    Seiter, Andreas
    Herbst, Christopher
    Pisani, Elizabeth
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2022, 100 (08) : 511 - 519
  • [43] Agenda setting for essential medicines policy in sub-Saharan Africa: a retrospective policy analysis using Kingdon’s multiple streams model
    Alison T. Mhazo
    Charles C. Maponga
    Health Research Policy and Systems, 19
  • [44] Agenda setting for essential medicines policy in sub-Saharan Africa: a retrospective policy analysis using Kingdon's multiple streams model
    Mhazo, Alison T.
    Maponga, Charles C.
    HEALTH RESEARCH POLICY AND SYSTEMS, 2021, 19 (01)
  • [45] Essential medicines for cancer: WHO recommendations and national priorities
    Robertson, Jane
    Barr, Ronald
    Shulman, Lawrence N.
    Forte, Gilles B.
    Magrini, Nicola
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2016, 94 (10) : 735 - 742
  • [46] Impact of the National Essential Public Health Services Policy on Hypertension Control in China
    Zhang, Donglan
    Pan, Xi
    Li, Shukai
    Liang, Di
    Hou, Zhiyuan
    Li, Yan
    Shi, Lu
    AMERICAN JOURNAL OF HYPERTENSION, 2018, 31 (01) : 115 - 123
  • [47] The essentiality and rationality of the Brazilian national listing of essential medicines
    Yamauti, Sueli Miyuki
    de Alcantara Bonfim, Jose Ruben
    Barberato-Filho, Silvio
    Lopes, Luciane Cruz
    CIENCIA & SAUDE COLETIVA, 2017, 22 (03): : 975 - 986
  • [48] WHO Essential Medicines Policies and Use in Developing and Transitional Countries: An Analysis of Reported Policy Implementation and Medicines Use Surveys
    Holloway, Kathleen Anne
    Henry, David
    PLOS MEDICINE, 2014, 11 (09)
  • [49] Essential Medicines in National Constitutions: Progress Since 2008
    Perehudoff, S. Katrina
    Toebes, Brigit
    Hogerzeil, Hans
    HEALTH AND HUMAN RIGHTS, 2016, 18 (01) : 141 - 156
  • [50] National list of essential medicines of India: The way forward
    Manikandan, S.
    Gitanjali, B.
    JOURNAL OF POSTGRADUATE MEDICINE, 2012, 58 (01) : 68 - 72
12345